PLMO-02 - Plenary session – Innovative drug discovery and access

Auditorium

Chair(s)

Prof. Ross Mckinnon, Chairman of the FIP Board of Pharmaceutical Sciences, Australia and Dr Rebecka Isaksson, FIP Scientific Secretary, UK

Introduction

This plenary session on innovative drug discovery and access will address current challenges, integrating industry-driven innovation with patient-centric clinical trials. A panel discussion titled, “Pharmacy’s role in bridging the gap,” will discuss new clinical trial models, innovative drug discoveries post-COVID-19 pandemic, and the role of pharmacists in improving access to groundbreaking medicines. It will showcase successful collaborations and recent breakthroughs in drug discovery.

Programme

16:30 – 16:45

SAHPRA support for health products innovation and development
D. Boitumelo Semete-Makokotlela, CEO, South African Health Products Regulatory Authority (SAHPRA), South Africa
16:45 – 17:00

Alignment of drug discovery and development strategies with unmet medical need – are we there yet?
Prof. Sarel Malan, INN Programme and Classification of Medical Products, World Health Organization and School of Pharmacy, University of Western Cape Town, South Africa
17:00 – 17:15

Integration of research and innovation into policy and practice through the paradigm of a learning health system
Dr Tim Hanlon, Group Manager Research, Evaluation and Innovation, Ministry of Health, New Zealand
17:15 – 17:30

Panel discussion and Q&A